Senores Pharmaceuticals Limited IPO is airing on 20 December 2024 and it will run until 24 December 2024. This book-built mainboard IPO is raising ₹582.11 crores from a mix of fresh issues and offers for sale. The company is issuing 1.28 crore fresh equity shares amounting to ₹ 500 crores and the remaining ₹ 82.11 crore will be raised via OFS of 21 lakh equity shares.
The allotment date for Senores Pharmaceuticals Ltd. IPO will be finalized on Thursday, 26 December 2024. Senores Pharmaceuticals shares will be probably listed on NSE and BSE on Monday, 30 December 2024 as decided as of now.
The price band of the Senores Pharmaceuticals IPO has been set between ₹372 and ₹391 apiece. The minimum ipo lot size is 38 shares for retail investors amounting to ₹14858 as minimum investment. For sNII, the minimum number of lots they have to subscribe to is 14 or 532 shares, amounting to ₹208012, and for bNII, the minimum number of lots is 68 or 2584 shares aggregating to ₹1010344.
Here Are the Quick Steps to Apply for the Senores Pharmaceuticals IPO with the Best Ipo App!
Senores Pharmaceuticals NSE BSE IPO Details
| Detail | Information |
| IPO Opening Date | December 20, 2024 |
| IPO Closing Date | December 24, 2024 |
| Tentative IPO Listing Date | December 30, 2024 |
| Face Value | ₹10 per share |
| Price Range | ₹372 to ₹391 per share |
| Lot Size | 38 shares |
| Total Issue Size | 14887723 shares (₹582.11 Cr) |
| Fresh Issue | 12787723 shares (₹ 500 Cr.) |
| OFS | 2100000 shares (₹82.11 Cr) |
| IPO Segment | Book Built Issue |
| Listing At | NSE & BSE |
| Share Holding Pre-Issue | 33265865 shares |
| NII (HNI) Shares Offered | 46053588 shares |
Senores Pharmaceuticals Limited | Company Overview
Senores Pharmaceuticals Limited as the name suggests is a manufacturer of a wide range of pharma products. It was started back in 2017 December and the pharma developer and manufacturer mostly serve the developed markets, which are highly regulated such as the UK, US, and Canada besides serving emerging countries as well.
The products of Senores Pharmaceuticals Ltd. are the following –
- Amphetamine Sulfate Tablets
- Hydroxychloroquine Sulfate Tablets
- Ketoconazole Tablets, Butalbital
- Risperidone Tablets
- Morphine Sulfate Tablets
- Methadone Hydrochloride Tablets
- Topiramate Capsules
- Ketorolac Tromethamine Tablets
- Diclofenac Potassium Tablets
- Diclofenac Potassium Tablets
- Nicardipine Hydrochloride Capsules
- Acetaminophen and Caffeine Capsules
- Mexiletine Hydrochloride Capsules
- Escitalopram Tablets
- Prochlorperazine Maleate Tablets USP
- Terazosin Capsules USP
- Cyclobenzaprine Hydrochloride Tablets
- Irbesartan Tablets
- Ivermectin Tablets
Apart from medicines, the pharma company also manufactures critical care injectables as well as APIs.
As of 30 September 2024, the company had three dedicated research and development facilities in the US and India, along with multiple partnerships with hospitals and distributors across Indian cities and states.
Want to subscribe to Senores Pharmaceuticals Ltd. IPO with Best Investment App? Open a Demat Account Today!
Senores Pharmaceuticals Limited IPO | Key Details
- Senores Pharmaceuticals IPO Opening Date: December 20, 2024,
- Senores Pharmaceuticals IPO Closing Date: December 24, 2024,
- Allotment Date: December 26, 2024
- Price Band: ₹372 to ₹ 391 per share
- Lot Size: 38 shares
- Refunds Initiated: December 27, 2024
- Shares Credited to Demat: December 27, 2024
- Listing Date: December 30, 2024
Senores Pharmaceuticals Ltd: Financial Overview
Senores Pharmaceuticals Limited saw one of the most profitable years in FY24. Its profit jumped by 288.02% while its revenue jumped by a whopping 457%. However, during the same period, the total borrowing also increased by 308.79%, which is of little concern.
Here are the details of the financials of the firm –
Amounts in ₹ Crore
| Financial Information | FY24 | FY23 | Absolute Change | Change (%) |
| Assets | 621.88 | 131.05 | 490.83 | 374.54 |
| Revenue | 217.34 | 39.02 | 178.32 | 457.00 |
| Profit After Tax | 32.71 | 8.43 | 24.28 | 288.02 |
| Net Worth | 231.71 | 45.5 | 186.21 | 409.25 |
| Reserve & Surplus | 175.94 | 35.25 | 140.69 | 399.12 |
| Total Borrowing | 248.38 | 60.76 | 187.62 | 308.79 |
FAQs | Senores Pharmaceuticals Ltd IPO
Senores Pharmaceuticals Ltd is engaged in the manufacturing of different medicines, and other pharmaceutical products such as injectables and others. It caters mainly to the regulated market as well as in the emerging countries.
The tentative IPO listing date of Senores Pharmaceuticals has been fixed as Monday, December 30, 2024.
The bidding date for the Senores Pharmaceuticals IPO is December 20, 2024, and it will continue until December 24, 2024.
The minimum IPO lot size for Senores Pharmaceuticals is 38 shares. For sNII, the minimum number of lots to be purchased is 14, while for bNII it is 68 lots.
The IPO allotment is expected to be finalized on Thursday, December 26, 2024.
The IPO face value is set at ₹10 per share.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.